Pacific Biosciences of California PACB
$ 1.95
0.78%
Quarterly report 2024-Q1
added 05-09-2024
Pacific Biosciences of California ROE Ratio 2011-2024 | PACB
Annual ROE Ratio Pacific Biosciences of California
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-43.74 | -55.83 | -22.91 | 8.76 | -153.2 | -89.92 | -107.07 | -87.84 | -43.1 | -120.4 | -114.62 | -86.36 | -57.13 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
8.76 | -153.2 | -74.87 |
Quarterly ROE Ratio Pacific Biosciences of California
2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-40.43 | -32.35 | -44.63 | -48.16 | -47.76 | -33.85 | -31.88 | -17.63 | -23.04 | -45.07 | -52.14 | -61.18 | -52.18 | -13.57 | -13.74 | -59.7 | -97.61 | -153.2 | -180.04 | -148.96 | -123.94 | -89.92 | -87.03 | -90.65 | -100.55 | -107.07 | -105.43 | -100.52 | -92.71 | -87.84 | -67.28 | -44.14 | -38.53 | -43.1 | -75.72 | -94.87 | -113.46 | -120.4 | -110.78 | -123.72 | -118.48 | -114.62 | -109.52 | -100.69 | -91.65 | -86.36 | -81.85 | -76.36 | -67.54 | -45.21 | -15.29 | -11.74 | -18.18 |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
-11.74 | -180.04 | -74.57 |